Group One Trading
TEVA icon

Group One Trading’s Teva Pharmaceuticals TEVA Stock Holding History

Group One Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.3M Sell
176,100
-226,800
-56% -$7.3M 0.01% 1256
2025
Q4 		$12.6M Sell
402,900
-349,700
-46% -$8.62M 0.02% 827
2025
Q3 		$15.2M Buy
752,600
+133,100
+21% +$2.34M 0.03% 649
2025
Q2 		$10.4M Buy
619,500
+68,700
+12% +$1.11M 0.02% 789
2025
Q1 		$8.47M Sell
550,800
-640,500
-54% -$11.4M 0.02% 730
2024
Q4 		$26.3M Buy
1,191,300
+328,600
+38% +$5.98M 0.06% 286
2024
Q3 		$15.5M Buy
862,700
+144,300
+20% +$2.53M 0.04% 382
2024
Q2 		$11.7M Sell
718,400
-15,700
-2% -$242K 0.05% 373
2024
Q1 		$10.4M Sell
734,100
-1,219,700
-62% -$15.4M 0.04% 421
2023
Q4 		$20.4M Buy
1,953,800
+126,300
+7% +$1.18M 0.05% 338
2023
Q3 		$18.6M Buy
1,827,500
+103,400
+6% +$963K 0.06% 252
2023
Q2 		$13M Sell
1,724,100
-106,200
-6% -$861K 0.04% 397
2023
Q1 		$16.2M Sell
1,830,300
-2,025,800
-53% -$20M 0.06% 271
2022
Q4 		$35.2M Buy
3,856,100
+646,500
+20% +$5.64M 0.08% 229
2022
Q3 		$25.9M Sell
3,209,600
-405,500
-11% -$3.59M 0.05% 293
2022
Q2 		$27.2M Sell
3,615,100
-781,400
-18% -$6.81M 0.04% 357
2022
Q1 		$41.3M Sell
4,396,500
-1,739,300
-28% -$14.5M 0.04% 310
2021
Q4 		$49.1M Buy
6,135,800
+3,676,500
+149% +$33.2M 0.04% 317
2021
Q3 		$24M Buy
2,459,300
+529,800
+27% +$4.96M 0.03% 538
2021
Q2 		$19.1M Buy
1,929,500
+382,500
+25% +$4.05M 0.02% 656
2021
Q1 		$17.9M Sell
1,547,000
-1,578,200
-50% -$18.1M 0.03% 601
2020
Q4 		$30.2M Buy
3,125,200
+600,900
+24% +$5.76M 0.05% 309
2020
Q3 		$22.7M Buy
2,524,300
+216,500
+9% +$2.29M 0.07% 233
2020
Q2 		$28.5M Sell
2,307,800
-1,323,300
-36% -$15M 0.13% 138
2020
Q1 		$32.6M Sell
3,631,100
-1,219,500
-25% -$12.5M 0.26% 59
2019
Q4 		$47.5M Buy
4,850,600
+1,683,300
+53% +$15M 0.32% 35
2019
Q3 		$21.8M Buy
3,167,300
+1,275,800
+67% +$9.77M 0.18% 97
2019
Q2 		$17.5M Buy
1,891,500
+1,243,500
+192% +$15M 0.16% 115
2019
Q1 		$10.2M Sell
648,000
-87,400
-12% -$1.54M 0.11% 192
2018
Q4 		$11.3M Sell
735,400
-279,100
-28% -$5.72M 0.1% 215
2018
Q3 		$21.9M Buy
1,014,500
+223,100
+28% +$5.18M 0.17% 109
2018
Q2 		$19.2M Sell
791,400
-206,500
-21% -$4.21M 0.16% 104
2018
Q1 		$17.1M Sell
997,900
-705,500
-41% -$13.8M 0.17% 107
2017
Q4 		$32.3M Buy
1,703,400
+103,900
+6% +$1.56M 0.23% 70
2017
Q3 		$28.2M Sell
1,599,500
-80,800
-5% -$1.82M 0.26% 62
2017
Q2 		$55.8M Buy
1,680,300
+182,500
+12% +$5.65M 0.58% 9
2017
Q1 		$48.1M Buy
1,497,800
+73,700
+5% +$2.52M 0.56% 16
2016
Q4 		$51.6M Buy
1,424,100
+733,200
+106% +$29.3M 0.5% 23
2016
Q3 		$31.8M Buy
690,900
+247,200
+56% +$12.9M 0.35% 49
2016
Q2 		$22.3M Sell
443,700
-800
-0.2% -$42.6K 0.26% 58
2016
Q1 		$23.8M Sell
444,500
-73,600
-14% -$4.32M 0.34% 36
2015
Q4 		$34M Buy
518,100
+110,700
+27% +$6.84M 0.4% 25
2015
Q3 		$23M Buy
407,400
+235,300
+137% +$15.3M 0.32% 31
2015
Q2 		$10.2M Buy
172,100
+141,100
+455% +$8.7M 0.14% 138
2015
Q1 		$1.93M Buy
+31,000
New +$1.8M 0.03% 665

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's TEVA Position: Q1 2026 in Review

Group One Trading sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 320,801 shares — an estimated $10.3M sold.

Group One Trading first reported a position in TEVA in Q1 2015 and held it in 39 quarters. The position peaked at $48.6M in Q4 2021. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Group One Trading reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 320,801 Teva Pharmaceuticals shares in Q1 2026, an estimated $10.3M.
  • Group One Trading first reported a position in Teva Pharmaceuticals in Q1 2015 and held it in 39 quarters.
  • Group One Trading's Teva Pharmaceuticals position peaked at $48.6M in Q4 2021.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.